Visible effect in 2 days… Bioderma, which has been number 1** in dermocosmetic skin care for years, continues to provide an effective skin care routine with the Sébium Series specially developed for combination, oily and acne-prone skin, while adding a brand new product to the series.
Formulated with clinical studies in its laboratories, Sébium Kerato+ Moisturizing Gel Cream provides an anti-acne, blackhead and anti-pore effect for acne-prone skin, and supports the prevention of post-acne blemishes. The product offers a visibly effective solution to the expectations of both young/adolescent women and men with acne-prone skin, as well as people with adult acne, in the 2nd day*.
The product, which provides moisture support to the skin, provides a high tolerance of 97% on the skin. It offers an effective solution against acne without irritating and irritating the skin. Thanks to its FluidactivTM*** patent, it supports the preservation of the sebum quality and balance of the skin, while preventing the formation and recurrence of new acne and blackheads by 41%, and plays an active role in reducing the appearance of acne spots by 36%. 10% malic acid ester in its content; While helping to regulate the sebum balance of the skin, it moisturizes the skin deeply. 1.8% salicylic acid; It helps to purify excess oil from the skin and cleans and tightens the pores, while offering an anti-pore and blackhead effect. Thanks to these powerful ingredients, Sébium Kerato+ Moisturizing Gel Cream shows anti-blackheads, acne and acne spots as of the second day. * It does not cause dryness, irritation and sensitivity on the skin and does not leave an oily feeling. Dermatologically tested. It is not comedogenic.
How to use:
Apply day and/or night to thoroughly cleansed skin with Sébium Foaming Gel and Sébium Foaming Gel Active. Apply to the entire face. It is suitable for acne-prone skin. Avoid eye contact.
*User test with 30 volunteers with oily and acne-prone skin under dermatological control, Eurofins n020E5071
**Based on the results of independent research conducted by IQVIA between 26 November 2021 and 20 December 2021.
*** FluidactivTM: Bioderma patent
